Foley Special Counsel David Charapp authored an article that appeared in Health Law360 on October 13, 2011 titled “Case Study: PharmAthene V. SIGA.”
Reprinted with permission from Portfolio Media, Inc.
Related Insights
November 7, 2025
Foley Viewpoints
Client Briefing: Texas Senate Bill 840 and Texas Senate Bill 2477 (89th Legislature, 2025 Session)
Texas S.B. 840 and S.B. 2477, effective September 1, 2025, significantly curtail how larger Texas cities regulate mixed-use and…
November 7, 2025
Energy Current
Uranium Designated as a US Critical Mineral in the 2025 USGS List: Three Things You Need to Know Now About this Landmark Action
On November 7, 2025 the U.S. Geological Survey (USGS), on behalf of the Secretary of the Interior, issued its Final 2025 List of Critical…
November 7, 2025
The Path & The Practice